The MTT assay, cell cycle analysis, and apoptosis analysis (using the flow cytometric Annexin V assay) demonstrated that the decrease in miR-21 levels led to inhibited cell growth in both U87 and LN229 GBM cells. The gene discussed is ANXA5; the disease is glioblastoma.